Mechanisms of Neurotransmitter-Gated Ion Channels

神经递质门控离子通道的机制

基本信息

项目摘要

The superfamily of pentameric ligand-gated ion channels (pLGICs) is one of the four superfamilies of synaptic ionotropic receptors present in animals; the other three are the excitatory glutamate receptors, the ATP-gated cation channels (P2X), and the acid-sensing ion channels (ASIC). Postsynaptic pLGICs mediate fast synaptic transmission, whereas presynaptic pLGICs modulate the release of other neurotransmitters. In addition, more recently, some pLGICs have been proposed to be involved in non-neuronal phenomena with the most compelling evidence suggesting a role for the α7 nicotinic acetylcholine receptor in inflammation. Importantly, pLGICs are the target of therapeutic drugs (such as benzodiazepines and anesthetics) and recreational drugs (such as nicotine), and their malfunction is often associated with neurological disease—including neuropathic pain in diabetic patients, congenital epilepsy, schizophrenia and Alzheimer's disease. Much is known about the structure and function of these ion channels. However, progress in rational drug design—undoubtedly, a most intriguing and potentially rewarding application of our basic knowledge—has lagged far behind in part because our understanding of how structure gives rise to function in pLGICs remains incomplete. Here, we propose experimental work (electrophysiology, radioligand-binding assays, and direct structural approaches) and computational work (molecular and Brownian dynamics simulations, and electrostatic calculations) that will allow us to: 1) Understand the “coupling” between ligand-binding and gating. We will challenge the prevailing view that the extracellular domain and the transmembrane domain form functionally autonomous units that need to be “coupled” for the channel to function as a whole; 2) Determine the structure of these channels in functionally well-defined states and elucidate the effect of the membrane on their conformational free-energy landscapes; and 3) Characterize the impact of side-chain conformation at the selectivity filter on cation-versus-anion selectivity. Collectively, these three aims cover the three most fundamental aspects of ligand-gated ion channels, namely, ligand binding, gating/desensitization, and ion conduction/charge selectivity.
五聚体配体门控离子通道(pLGICs)超家族是突触传递的四个超家族之一, 离子型受体存在于动物;其他三个是兴奋性谷氨酸受体,ATP门控 阳离子通道(P2 X)和酸敏感离子通道(ASIC)。突触后pLGIC介导快速突触 突触前pLGIC调节其他神经递质的释放。此外,更 最近,一些pLGIC被认为与非神经元现象有关, 令人信服的证据表明α7烟碱乙酰胆碱受体在炎症中的作用。重要的是, pLGIC是治疗药物(如苯二氮卓类和麻醉剂)和娱乐药物的靶点 (such尼古丁),它们的功能障碍通常与神经系统疾病有关,包括神经性 糖尿病患者的疼痛,先天性癫痫,精神分裂症和阿尔茨海默病。多少人知道 这些离子通道的结构和功能然而,合理药物设计的进展-毫无疑问, 最有趣和潜在的有益的应用我们的基本知识-已经远远落后,部分 因为我们对pLGIC的结构如何产生功能的理解仍然不完整。这里我们 提出实验工作(电生理学,放射性配体结合测定和直接结构方法) 和计算工作(分子和布朗动力学模拟,以及静电计算), 将使我们能够:1)理解配体结合和门控之间的“耦合”。我们将挑战 细胞外结构域和跨膜结构域形成功能自主的流行观点 需要“耦合”的通道作为一个整体运行的单元; 2)确定这些单元的结构 通道的功能明确的状态,并阐明其构象的膜的影响 自由能景观;和3)表征选择性过滤器处的侧链构象对 阳离子对阴离子选择性。总的来说,这三个目标涵盖了以下三个最基本的方面: 配体门控离子通道,即配体结合、门控/脱敏和离子传导/电荷 选择性

项目成果

期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Block of muscle nicotinic receptors by choline suggests that the activation and desensitization gates act as distinct molecular entities.
胆碱肌肉烟碱受体的块表明,激活和脱敏的门是不同的分子实体。
Probing function in ligand-gated ion channels without measuring ion transport.
An experimental test of the nicotinic hypothesis of COVID-19.
Structure and function at the lipid-protein interface of a pentameric ligand-gated ion channel.
五聚体配体门控离子通道的脂质-蛋白质界面的结构和功能。
Tunable pKa values and the basis of opposite charge selectivities in nicotinic-type receptors.
  • DOI:
    10.1038/nature10015
  • 发表时间:
    2011-05-22
  • 期刊:
  • 影响因子:
    64.8
  • 作者:
    Cymes, Gisela D.;Grosman, Claudio
  • 通讯作者:
    Grosman, Claudio
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CLAUDIO F GROSMAN其他文献

CLAUDIO F GROSMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CLAUDIO F GROSMAN', 18)}}的其他基金

Mechanisms of Neurotransmitter-gated Ion Channels
神经递质门控离子通道的机制
  • 批准号:
    9477921
  • 财政年份:
    2017
  • 资助金额:
    $ 41.11万
  • 项目类别:
Mechanisms of Neurotransmitter-gated Ion Channels
神经递质门控离子通道的机制
  • 批准号:
    8074368
  • 财政年份:
    2003
  • 资助金额:
    $ 41.11万
  • 项目类别:
Mechanisms of Neurotransmitter-gated Ion Channels
神经递质门控离子通道的机制
  • 批准号:
    8315329
  • 财政年份:
    2003
  • 资助金额:
    $ 41.11万
  • 项目类别:
Mechanisms of Neurotransmitter-gated Ion Channels
神经递质门控离子通道的机制
  • 批准号:
    7869064
  • 财政年份:
    2003
  • 资助金额:
    $ 41.11万
  • 项目类别:
Mechanisms of Neurotransmitter-gated Ion Channels
神经递质门控离子通道的机制
  • 批准号:
    6876703
  • 财政年份:
    2003
  • 资助金额:
    $ 41.11万
  • 项目类别:
Mechanisms of Neurotransmitter-gated Ion Channels
神经递质门控离子通道的机制
  • 批准号:
    8849979
  • 财政年份:
    2003
  • 资助金额:
    $ 41.11万
  • 项目类别:
Mechanisms of Neurotransmitter-gated Ion Channels
神经递质门控离子通道的机制
  • 批准号:
    6610147
  • 财政年份:
    2003
  • 资助金额:
    $ 41.11万
  • 项目类别:
Mechanisms of Neurotransmitter-gated Ion Channels
神经递质门控离子通道的机制
  • 批准号:
    7540970
  • 财政年份:
    2003
  • 资助金额:
    $ 41.11万
  • 项目类别:
Mechanisms of Neurotransmitter-gated Ion Channels
神经递质门控离子通道的机制
  • 批准号:
    8440741
  • 财政年份:
    2003
  • 资助金额:
    $ 41.11万
  • 项目类别:
Mechanisms of Neurotransmitter-gated Ion Channels
神经递质门控离子通道的机制
  • 批准号:
    7051956
  • 财政年份:
    2003
  • 资助金额:
    $ 41.11万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 41.11万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.11万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 41.11万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.11万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 41.11万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.11万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 41.11万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 41.11万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 41.11万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.11万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了